pCAGGS-SARS2-S-G614 (C-flag) Citations (4)

Originally described in: SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, Rangarajan ES, Pan A, Vanderheiden A, Suthar MS, Li W, Izard T, Rader C, Farzan M, Choe H Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4. PubMed Journal

---

Articles Citing pCAGGS-SARS2-S-G614 (C-flag)

Articles
Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry. Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL. Viruses. 2021 Jun 26;13(7). pii: v13071246. doi: 10.3390/v13071246. PubMed
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy. Minenkova O, Santapaola D, Milazzo FM, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Gritti G, Borleri G, Rambaldi A, Dental C, Viollet C, Pagano B, Salvini L, Marra E, Luberto L, Rossi A, Riccio A, Merlo Pich E, Santoro MG, De Santis R. Mol Ther. 2022 May 4;30(5):1979-1993. doi: 10.1016/j.ymthe.2022.02.013. Epub 2022 Feb 12. PubMed
Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence. Riccio A, Santopolo S, Rossi A, Piacentini S, Rossignol JF, Santoro MG. Cell Mol Life Sci. 2022 Apr 7;79(5):227. doi: 10.1007/s00018-022-04246-w. PubMed
Convergent activation of two-pore channels mediated by the NAADP-binding proteins JPT2 and LSM12. Gunaratne GS, Brailoiu E, Kumar S, Yuan Y, Slama JT, Walseth TF, Patel S, Marchant JS. Sci Signal. 2023 Aug 22;16(799):eadg0485. doi: 10.1126/scisignal.adg0485. Epub 2023 Aug 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.